RxDoctor Payments Data

Joseph Washburne, MD

Obstetrics & Gynecology · Hattiesburg, MSNPI 1750354247

Payments from drug & device makers

What this record shows

This record is dominated by education: $6,000 of the $7,595 with a category attached, or 79.0%. Intuitive Surgical accounts for 81.5% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2020 at $3,277 and has fallen 95.5% since, to $147 in 2025. Among obstetrics & gynecology clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,595in general payments, 2019–2025

Across 88 payments — averaging $86.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$6K
  • AbbVie$422
  • Pfizer$141
  • Mayne Pharma Commercial LLC$141
  • Avion Pharmaceuticals$134
  • Hologic Sales And Service, LLC$81
  • plus $484 from 21 others

What the payments were for

  • Food & beverage$1,59521%
  • Education$6,00079%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,595 in reported general payments places this provider in the 90th percentile of 318 obstetrics & gynecology providers in Mississippi.

See all obstetrics & gynecology providers in Mississippi

Medicare billing

Part B allowed, 2024
$47,762
Medicare patients
169
Services billed
760

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron14$7,878
Estradiol82$3,096
SynthroidLevothyroxine Sodium12$537
Raloxifene Hcl20$396
Oxybutynin Chloride26$364
Rosuvastatin Calcium19$157
Alendronate Sodium30$140
Escitalopram Oxalate11$98
Fluconazole12$89
Gabapentin33$88
Medroxyprogesterone Acetate11$76
Clonidine Hcl34$62

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$16$7,87814 claims
AbbVieSynthroid$422$53712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 318 obstetrics & gynecology providers in Mississippi.

Other obstetrics & gynecology in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →